Corporate strategy - GHW International

ABOUT US

The company has currently established a comprehensive product platform centered on the "4+1" intermediate system, namely "4": methylamine, iodine derivatives, advanced material intermediates, and green products; "1": pharmaceutical intermediates, which have achieved large-scale deployment in multiple niche sectors. The related products possess strong cost-control capabilities and industrial chain synergy advantages, forming the core of the company's business system.

On the basis of gradual maturity of core businesses and continuous enrichment of product portfolios, the company has simultaneously pursued downward compatibility by integrating trading products, applied chemicals, and other operations through Goldenhighway New Materials. Leveraging capabilities in logistics, warehousing, e-commerce platforms, and risk management, it enhances the commercialization efficiency of intermediate products and expands customer coverage, establishing a central platform linkage between products and markets.

At the same time, the company is exploring diversified terminal pathways around end-use scenarios, with a layout covering consumer brands (Happy Elephant), daily chemical products (Ai Ruyi), human health, terminal pharmaceutical product sales, and overseas market expansion. This move not only brings the company closer to end-users but also unleashes the industrial extension potential of its intermediate product business.

Through the orderly articulation of product platforms, synergy platforms, and terminal scenarios, the company has gradually established an integrated business system with vertical integration and horizontal coordination, providing support for medium-to-long-term growth and market space expansion.